Lung infections in children with chronic lung disease of prematurity
Part of Lungs & breathing clinical trials.
This study looks at children born very early who have chronic lung disease (BPD) and get a lung infection. Doctors want to learn more about how these infections affect breathing and health over time.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Your child is currently sick with a lung infection (like pneumonia or bronchiolitis).
- Your child was born before 32 weeks of pregnancy.
- Your child has been diagnosed with bronchopulmonary dysplasia (BPD).
- Your child's corrected age is between about 1 month and 7 years old (corrected age means how old they would be if born on their due date).
- Your child does not have a serious heart problem, nerve/muscle disorder, genetic syndrome, or another major lung condition.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study uses ultrasound images of the lungs to see if doctors can predict which very premature babies will develop bronchopulmonary dysplasia (BPD)—a chronic lung condition common in extremely premature infants. The goal is to identify at-risk babies early so they can receive targeted treatment.
This study looks at babies born very early who have severe lung disease (grade 3 BPD) and still need a breathing machine. Researchers will use tests to understand their lung problems better, which may help guide their care.
This study looks at how viruses that babies encounter early in life might affect their lung development, specifically a condition called bronchopulmonary dysplasia (BPD), which is a chronic lung disease in premature infants. The goal is to understand if certain viruses increase the risk, which could lead to better prevention or treatment.
This study looks at the natural bacteria and germs in a premature baby's airways to see if they can help predict whether the baby will develop a lung problem called bronchopulmonary dysplasia (BPD). The goal is to find early clues that help doctors take better care of these babies.
This trial tests whether giving intravenous immunoglobulin (IVIG) early after birth can help prevent or treat a serious lung condition called bronchopulmonary dysplasia (BPD) in babies born at 28 weeks or earlier. It may help reduce the need for breathing support and oxygen.
This study looks at very early signs of a lung problem called bronchopulmonary dysplasia in babies born before 26 weeks of pregnancy. The goal is to find better ways to predict and maybe prevent this condition.
Hear when a new Severe Respiratory Exacerbation trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.